http://rdf.ncbi.nlm.nih.gov/pubchem/reference/36859996

Outgoing Links

Predicate Object
contentType Journal Article|Review
issn 1559-131X
issueIdentifier 3
pageRange 75-
startingPage 75
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_3ee930faeab2b7df6f3aa91519d1e495
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_cb24aad60895a4efb767fed618c0b196
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_84e0ab66803bd7bce96d48be3ac7df36
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_551a3c2607ae45dedb226bfb22893457
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_d38a7e3e024fb630d9df0b5a973a14f6
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_2a928af5ba5bcc47c9ea04e007885a56
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_0bdb99a568bda731e7cb2c91768ef30b
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_1b57780d902675bd57b688dac8ee94c4
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_1c0aa062611518a12552a116a65f748d
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_adc03d2c70c5e30b5f568532b3ab3806
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_20112bfb0778fead6fcbb6c661dfd70d
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b8dfc5ac3f3ef614e6acd94d22a887c8
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_d813a34c1e4381504d2b075a53f74917
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_badf620a43ffa5505ae6507eef5e9090
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_4ed3ec3464efbd75e7f40c84ed64cb26
bibliographicCitation You Q, Li R, Yao J, Zhang YC, Sui X, Xiao CC, Zhang JB, Xiao JQ, Chen HT, Li H, Zhang J, Zheng J, Yang Y. Insights into lenvatinib resistance: mechanisms, potential biomarkers, and strategies to enhance sensitivity. Med Oncol. 2024 Feb 21;41(3):75. doi: 10.1007/s12032-023-02295-0. PMID: 38381181.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4ae2703b8dfe7f5638eb99743fbf0eb1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_72349624c57d159e8df334b367ecc40a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645bd5c7c983695f685c121707d165d3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3e2915c3678c0a6812af33990ec3e320
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e281fca16a145bca9cf2a74dd640dbf7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_840554fd804bcf7f3b216d8999d37ed2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b9c8178d6cbb2333b4612bd3303aeeba
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ac23f74258bb91aef71f71d68f6b56f1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-4283-0403
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f2335ed09d059556662d247a773391c0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_95414a47d928e2c42043adb245a2548b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f319a04568446d81a8f6d1da4c7a25ff
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1f8b3e5468794393032e21fefba2fea5
date 2024-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1007/s12032-023-02295-0
https://pubmed.ncbi.nlm.nih.gov/38381181
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8582
https://portal.issn.org/resource/ISSN/1559-131X
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Insights into lenvatinib resistance: mechanisms, potential biomarkers, and strategies to enhance sensitivity
discusses http://id.nlm.nih.gov/mesh/M0575909
http://id.nlm.nih.gov/mesh/M0018350
http://id.nlm.nih.gov/mesh/M0023752
http://id.nlm.nih.gov/mesh/M0016578

Total number of triples: 48.